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Abstract 
Objective: Marshall Syndrome or PFAPA is an inflammatory periodic disease characterized by periodic fever, 
aphthous stomatitis, pharyngitis and cervical adenitis. Although PFAPA is an auto inflammatory disease, it 
doesn't have genetic basis such as other periodic fevers. This study evaluates the 12 common MEFV gene 
mutations in patients with PFAPA syndrome. 
Methods: 21 patients with PFAPA syndrome who had diagnostic criteria were enrolled in this study and 12 
common MEFV gene mutations i.e. P369S, F479L, M680I (G/C), M680I (G/A), I692del, M694V, M694I, K695R, 
V726A, A744S, R761H, E148Q evaluated. All the patients were screened for MEFV gene mutations by a 
reverse hybridization assay (FMF Strip Assay, Vienna lab, Vienna, Austria) according to the instructions 
provided by the manufacturer. 
Findings: The age of patients was between 6 months to 14 years, and 15 were males. Seven patients had 
heterozygote and one had compound heterozygote (K695R, V725A) mutation. There were 4 alleles M694V, 3 
alleles V726A, 1 allele E148Q and 1 allele K694R. No significant difference existed between mutated patients 
with non-mutated in symptoms like aphthous and stomatitis, duration of attacks, episodes of fever and 
response to treatment. Gaslini score test was not helpful to predict the probability of gene mutations. 
Conclusion: About 30 percent of patients had MEFV gene mutations but these mutations did not play a main 
role in presentation of PFAPA symptoms. 
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Introduction 
Marshall Syndrome was first defined by Marshal 
in 1987[1]. The acronym FAPA (fever, aphthous 
stomatitis, pharyngitis, cervical adenitis) was was 
later renamed to PFAPA (periodic fever, aphthous 
stomatitis, pharyngitis, and cervical adenitis)[2]. 
This clinical syndrome occurs among children less 
than 5 years old. It is a sporadic disease with 
periodic attacks of inflammation[3]. Periodic fevers 
usually last 3 to 6 days and occur with regular 
intervals about every 3 to 6 weeks. The diagnosis 
is established on the basis of clinical criteria that 
require the presence of a recurrent fever of early 
onset (<5 years) and ≥1 of the 3 associated 
symptoms (aphthosis, cervical adenitis, and 
pharyngitis) in the absence of upper respiratory 
tract infections and cyclic neutropenia[2]. 
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     Between episodes, the children usually are well.  
The exact cause of PFAPA is unknown and 
autoimmune or infectious processes in its 
pathogenesis are not proven. Moreover no 
geographical or ethnic tendencies have been 
shown. WBC and ESR are increased during acute 
episodes[4]. Because a single dose of corticosteroid 
can resolve attacks, inflammatory cytokines 
production in response to infectious factors is 
considered as a leading cause of the syndrome. 
IFN-γ, TNF and IL-6 increase during episodes[5,6]. It 
is more common in males and the prognosis is 
very good[7,8].   
     PFAPA has been reported in adult patients 
too[9,10]. Although PFAPA is a periodic fever, no 
specific gene mutation is known for it. 
Nevertheless it is possible that genes involved in 
other inflammatory diseases play a role in its 
pathogenesis[2].  
     In Cazeneuve’s study among 12 allele analysis 
only one mutation of M694V was found[11]. Berkun 
study showed that in PFAPA patients with MEFV 
gene mutation the disease was less severe and 
aphthous stomatitis, duration of disease, number 
of attacks, and need to steroid were less common. 
Therefore they found MEFV gene effect as a 
modifier on PFAPA[12].  
     In a study on 393 children with PFAPA, the 
clinical features were compared in genetically 
negative and positive results, 82 had positive 
genetic results, 75 uncertain and 236 negative 
results. Jn patients with positive genetic results 
diarrhea, vomiting, arthralgia and rash was more 
frequent. In the genetically negative group 
exudative pharyngitis was encountered more 
frequently[13]. 
     Gattorno et al evaluated the relationship 
between PFAPA and other periodic fevers such as 
FMF, MVK, and TRAPS. They found a close 
relationship between PFAPA and other periodic 
fever syndromes[14]. 
     FMF is an autosomal recessive disease 
characterized by acute attacks of fever and 
polyserositis. This disease mainly occurs in 
Mediterranean population and is caused by MEFV 
gene mutations[2]. This study was designed to 
analyse 12 most common MEFV gene mutations in 
PFAPA patients and also evaluating Gaslini score 
test based on detected mutations. 
Subjects and Methods  
Twenty one patients who had diagnostic criteria 
were enrolled in this study. Twelve common 
MEFV gene mutations were evaluated: P369S, 
F479L, M680I(G/C), M680I(G/A), I692del, M694V, 
M694I, K695R, V726A, A744S, R761H, E148Q. All 
the patients were screened for 12 common MEFV 
mutations by a reverse hybridization assay (FMF 
StripAssay, Vienna lab, Vienna, Austria) according 
to the instructions provided by the manufacturer. 
Statistical analysis was performed using SPSS 16.0. 
Comparison between the different genotypes was 
assessed using chi-square test. A P-value <0.05 
was accepted as statistically significant. 
Findings 
The age of patients was between 6 months and 14 
years, and 15 were males. The mean age at onset 
of symptoms was 1.52±2.72 years (range 6 
months - 5 years). The mean duration of fever was 
3.57±1.64 days, and that of the disease 4.23±1.56 
days. The interval of the attacks was 32.52±20.53 
days. All of the patients had fever and 12 (57.14%) 
patients had abdominal pain, 19 (90.47%) 
children were breast fed infants. 
     In family history one patient's brother, one 
patient's father and one patient's mother had FMF. 
Eight (38.09%) patients had MEFV gene 
mutations, seven of them were heterozygotes and 
one was combined heterozygous (K695R, V725A).  
(Table 1). 
     Although abdominal pain, aphthous stomatitis 
and duration of attacks were more common in 
non-mutated patients, these findings in 
association with episodes of fever and response to 
treatment did not show meaningful difference 
between the two groups (P≤0.05). 
Table 1: Prevalence of MEFV gene mutations      
MEFV Gene Prevalence Percent 
M694V 4 45 
V726A 3 33 
K694R 1 11 
E148Q 1 11 
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Table 2: Clinical findings in different studies 
Signs and symptoms Our study 
% 
Gattorno[14] 
% 
Stojanov[15] 
% 
Padeh[8] 
% 
Dagan[16] 
% 
Fever 100 -- 78 100 -- 
Weakness and lethargy 71.42 -- -- 100 -- 
Skin rash 14.28 24 18 -- -- 
Headache 28.6 46 6.5 17.8 -- 
Oral aphthosis 47.61 63 13 67.8 33.3 
Abdominal pain 57.14 68 42 17.8 35.1 
Myalgia 61.9 3.5 -- -- -- 
Diarrhea -- 36 -- -- -- 
Vomiting -- 41 -- -- -- 
Arthralgia 13 49 -- 10.7 -- 
 
Discussion 
Padeh[8], Stojanov [15] and Dagan [16] studies in 
comparison with our results are shown in Table 2. 
Table 3 shows our results and those of Gattornos. 
     Bonyadi revealed that the carrier rate of five 
common MEFV genes in the Azeri Turkish 
population was 25.5%, with E148Q being the most 
common (11.5%) mutation followed by V726A 
(1.75%). This study indicates that the FMF carrier 
rate and E148Q mutation frequency are high in the 
Iranian Azeri Turkish population[17] and one of our 
studies showed the frequency of E148Q mutation 
in FMF patients to be 9.95% (in press). It does not 
seem that these MEFV mutations in PFAPA 
patients are related to normal population 
varieties. 
     The authors have known two siblings suffering 
from FMF with M694V – V726A gene mutation, 
and PFAPA syndrome, offspring of whom one had 
monozygotic mutation M694V and the other 
monozygotic mutation V726A. 
     In other authors’ experience there were 2 
patients who had FMF and PFAPA simultaneously, 
it was observed that the first patient had R761H-
M694I combined mutations and the second one 
M680I monozygotic mutation. 
     It seems that there is a genetic similarity, on the 
basis of pathogenesis, between FMF and PFAPA. 
This genetic similarity has led to suggest a scoring 
Table 3: MEFV genes mutations in two studies 
Gattorno(14) Our study  Heterozygote 
No of Mutation= 40 No of Mutation= 8  
7 1 Number 
Compound 
Heterozygote  
M694V/V726A 
M680I/V726A 
M694V/E148Q 
L110P/L110P 
V726A/E148Q 
V726A/S108R 
P369S/R408Q 
K695R/ V726A Type of Mutation 
33 7 Number 
Heterozygote 
E148Q (11) 
K695R (5) 
M694V (4) 
A744S (3) 
V726A (2) 
P369S (1) 
V487M (1) 
R408Q (1) 
M680I (1) 
R717L (1) 
M694V (4) 
V726A (2) 
E148Q (1) 
Type of Mutation 
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Table 4: Gaslini score in our patients 
No Age Sex Age at 
Onset 
Abd 
pain 
Diarrhea Chest 
pain 
Aphtous 
stomatitis 
Genotype Family 
history 
Gaslini 
score 
1 5 Boy 2y Yes No No No Wt- Wt No -0.027  
2 7 Boy 3y Yes Yes No Yes Wt-M694V No +1.38 
3 5 Boy 2y No No No No Wt- Wt No -1.608 
4 13 Girl 6 mo Yes No No Yes Wt- Wt No +1.082 
5 6 Boy 4y Yes No No No Wt- Wt No -0.228 
6 7 Boy 6y Yes No No Yes Wt- Wt No -3.34 
7 4 Girl 2y Yes No No Yes Wt- Wt No -0.124 
8 5 Boy 3y No No No No Wt- Wt No -2.412 
9 5 Girl 1y No No No Yes Wt-V726A Father: FMF -0.802 
10 5 Boy 10 mo No No No No Wt- Wt No -0.67 
11 12 Boy 2y No No No Yes Wt- Wt No -3.112 
12 12 Boy 3y No No No No Wt-M694V No -2.412 
13 12 Boy 2y Yes No No Yes Wt- Wt 
Brother: 
Periodic Fever 
+1.379 
14 4 Boy 6 mo Yes No No Yes Wt- Wt No +1.082 
15 14 Girl 6y Yes No No No Wt-E148Q No -1.836 
16 9 Boy 3y No No No Yes Wt- Wt No -3.916 
17 10 Boy 5y Yes No No Yes Wt-M694V No -2.536 
18 13 Boy 5y No No No Yes 
K695R-
V726A 
No -5.524 
19 8 Boy 2y No No No Yes Wt-M694V No -3.112 
20 7 Girl 3y Yes No No Yes Wt-V726A Mother: FMF +0.575 
21 8 Girl 3y Yes No No Yes Wt- Wt No -0.928 
 
system in genetic analysis of periodic fever 
syndromes in PFAPA patients[13]. This scoring is 
based on clinical criteria and is called Gaslini 
diagnostic score. If a PFAPA patient has scored 
above 1.32, he/she will be in a high risk of having 
others periodic fever syndromes. 
     In Gattorno study it was observed that Gaslini 
diagnostic score is a useful diagnostic tool in 
evaluating differential diagnosis of PFAPA 
syndrome. 
     Because 38 percent of PFAPA patients in this 
study had MEFV gene mutations, it seems that 
genetic basis of FMF has a role in pathogenesis of 
PFAPA; however there is no significant difference 
between mutation positive and negative patients 
in duration of disease, episodes of disease and 
response to treatment. Table 4 shows patients’ 
Gaslini diagnostic scoring test. 
Conclusion 
This scoring was not helpful to predict the 
probability of MEFV gene mutation (12 common 
mutations) in our study and in these patients it 
has also been shown that MEFV gene mutation 
doesn't have any specific effect in patient’s clinical 
manifestations. We should find another way to 
predict the presence of MEFV gene mutations in 
this syndrome. 
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